Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1993;2(5):391–395. doi: 10.1155/S0962935193000559

Arachidonic acid metabolism in TNS-induced chronic and immunologic enteritis in rats, and the effect of 5-ASA

F J Zijlstra 1,✉, A P M van Dijk 1, N Selve 2, J H P Wilson 3
PMCID: PMC2365421  PMID: 18475551

Abstract

Inflammation of the rat distal intestine was induced by intradermal sensitization and subsequent multiple intrajejunal challenge with the hapten 2,4,6-trinitrobenzenesulphonic acid (TNBS) via an implanted catheter. The time course of the inflammatory reaction was followed by determination of the enteritis score and measurement of in vitro eicosanoid formation of homogenates of the gut after 0, 1, 2, 4, 7, 14 and 21 days of local daily challenge with 0.08% TNBS. There was a small initial increase of eicosanoid formation, reached at days 1 and 2, followed by a significant increase in metabolism of arachidonic acid on day 21. Although at day 1 a four-fold increase in inflammation score was reached, no further significant changes were observed during the following 3 weeks. The greatest increase in metabolite formation was observed in prostanoids TxB2, PGE2. and PGD2 and the 5-lipoxygenase product LTC4, whereas minor changes were found for LTB4 and other lipoxygenase products such as 12- and 15-HETE. The formation of these metabolites was already inhibited by low-dose 5-aminosalicylic acid (5-ASA), given orally twice daily during the 3 weeks challenge period, while the enteritis score was affected dosedependently.

Full Text

The Full Text of this article is available as a PDF (570.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aderka D., Englemann H., Hornik V., Skornick Y., Levo Y., Wallach D., Kushtai G. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res. 1991 Oct 15;51(20):5602–5607. [PubMed] [Google Scholar]
  2. Arend W. P., Dayer J. M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum. 1990 Mar;33(3):305–315. doi: 10.1002/art.1780330302. [DOI] [PubMed] [Google Scholar]
  3. Bianco J. A., Appelbaum F. R., Nemunaitis J., Almgren J., Andrews F., Kettner P., Shields A., Singer J. W. Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood. 1991 Sep 1;78(5):1205–1211. [PubMed] [Google Scholar]
  4. Dayer J. M., Fenner H. The role of cytokines and their inhibitors in arthritis. Baillieres Clin Rheumatol. 1992 Jun;6(2):485–516. doi: 10.1016/s0950-3579(05)80186-4. [DOI] [PubMed] [Google Scholar]
  5. Giavazzi R., Chirivi R. G., Garofalo A., Rambaldi A., Hemingway I., Pigott R., Gearing A. J. Soluble intercellular adhesion molecule 1 is released by human melanoma cells and is associated with tumor growth in nude mice. Cancer Res. 1992 May 1;52(9):2628–2630. [PubMed] [Google Scholar]
  6. Jasin H. E., Taurog J. D. Mechanisms of disruption of the articular cartilage surface in inflammation. Neutrophil elastase increases availability of collagen type II epitopes for binding with antibody on the surface of articular cartilage. J Clin Invest. 1991 May;87(5):1531–1536. doi: 10.1172/JCI115164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Josaki K., Contrino J., Kristie J., Krause P., Kreutzer D. L. Pentoxifylline-induced modulation of human leukocyte function in vitro. Am J Pathol. 1990 Mar;136(3):623–630. [PMC free article] [PubMed] [Google Scholar]
  8. Lala P. K., Parhar R. S. Cure of B16F10 melanoma lung metastasis in mice by chronic indomethacin therapy combined with repeated rounds of interleukin 2: characteristics of killer cells generated in situ. Cancer Res. 1988 Mar 1;48(5):1072–1079. [PubMed] [Google Scholar]
  9. Metcalf D. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature. 1989 May 4;339(6219):27–30. doi: 10.1038/339027a0. [DOI] [PubMed] [Google Scholar]
  10. Morstyn G., Burgess A. W. Hemopoietic growth factors: a review. Cancer Res. 1988 Oct 15;48(20):5624–5637. [PubMed] [Google Scholar]
  11. Movat H. Z., Cybulsky M. I., Colditz I. G., Chan M. K., Dinarello C. A. Acute inflammation in gram-negative infection: endotoxin, interleukin 1, tumor necrosis factor, and neutrophils. Fed Proc. 1987 Jan;46(1):97–104. [PubMed] [Google Scholar]
  12. Nelson J. A., Parhar R. S., Scodras J. M., Lala P. K. Characterization of macrophage subsets regulating murine natural killer cell activity. J Leukoc Biol. 1990 Nov;48(5):382–393. doi: 10.1002/jlb.48.5.382. [DOI] [PubMed] [Google Scholar]
  13. Parhar R. S., Ernst P., Sheth K. V., al-Sedairy S. T. Anti-tumor cytotoxic potential and effect on human bone marrow GM-CFU of human LAK cells generated in response to various cytokines. Eur Cytokine Netw. 1992 May-Jun;3(3):299–306. [PubMed] [Google Scholar]
  14. Parhar R. S., Lala P. K. Amelioration of B16F10 melanoma lung metastasis in mice by a combination therapy with indomethacin and interleukin 2. J Exp Med. 1987 Jan 1;165(1):14–28. doi: 10.1084/jem.165.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Parhar R. S., Lala P. K. Changes in the host natural killer cell population in mice during tumor development. 2. The mechanism of suppression of NK activity. Cell Immunol. 1985 Jul;93(2):265–279. doi: 10.1016/0008-8749(85)90133-9. [DOI] [PubMed] [Google Scholar]
  16. Parhar R. S., Lala P. K. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages. J Leukoc Biol. 1988 Dec;44(6):474–484. doi: 10.1002/jlb.44.6.474. [DOI] [PubMed] [Google Scholar]
  17. Patarroyo M., Makgoba M. W. Leucocyte adhesion to cells. Molecular basis, physiological relevance, and abnormalities. Scand J Immunol. 1989 Aug;30(2):129–164. doi: 10.1111/j.1365-3083.1989.tb01197.x. [DOI] [PubMed] [Google Scholar]
  18. Schandené L., Vandenbussche P., Crusiaux A., Alègre M. L., Abramowicz D., Dupont E., Content J., Goldman M. Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells. Immunology. 1992 May;76(1):30–34. [PMC free article] [PubMed] [Google Scholar]
  19. Sewell K. L., Trentham D. E. Pathogenesis of rheumatoid arthritis. Lancet. 1993 Jan 30;341(8840):283–286. doi: 10.1016/0140-6736(93)92627-6. [DOI] [PubMed] [Google Scholar]
  20. Smith C. W., Marlin S. D., Rothlein R., Toman C., Anderson D. C. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest. 1989 Jun;83(6):2008–2017. doi: 10.1172/JCI114111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sullivan G. W., Carper H. T., Novick W. J., Jr, Mandell G. L. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Immun. 1988 Jul;56(7):1722–1729. doi: 10.1128/iai.56.7.1722-1729.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Weinberg J. B., Mason S. N., Wortham T. S. Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) messenger RNA (mRNA) expression in HL-60 leukemia cells by pentoxifylline and dexamethasone: dissociation of acivicin-induced TNF-alpha and IL-1 beta mRNA expression from acivicin-induced monocytoid differentiation. Blood. 1992 Jun 15;79(12):3337–3343. [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES